Peptid-Klartext DE Community
Guide · Research peptides: studies, quality & law

Stacking peptides: what is known about combinations – and what isn't

In short: There are no studies testing the efficacy and safety of stacks made from unapproved peptides – every extra substance adds more unknowns. Clearly risky: two GLP-1 drugs at the same time, and GLP-1 drugs together with insulin or sulfonylureas (low blood sugar). Tested combinations only exist where manufacturers have studied them, such as CagriSema.
Share via WhatsApp

What a “stack” means

A stack is the simultaneous use of several substances in the hope of a stronger or broader effect together. Well-known examples from forums and groups are BPC-157 with TB-500 (often called “Wolverine”), GLP-1 drugs with growth-hormone peptides, or ready-made blends with three or four active ingredients in one vial.

The difference matters: drawing up two substances in one syringe is a question of technique (see Drawing up two peptides together). Whether the combination makes sense and is safe is a completely different question – and that is what this page is about.

Why there is hardly any data on stacks

Even most single peptides such as BPC-157, TB-500 or ipamorelin have barely been studied in humans. For combinations there is practically nothing: no studies on interactions, on side effects in combination, or on whether the hoped-for extra benefit even occurs.

  • If a side effect occurs, you don't know which substance caused it.
  • Every additional grey-market substance brings its own quality risk (purity, content, endotoxins).
  • Ready-made blends can't be adjusted or stopped individually.
  • Experience reports from groups are not evidence – they mainly show who feels good.

Combinations that are demonstrably risky

CombinationRisk
Two GLP-1 drugs at once (e.g. tirzepatide + semaglutide or retatrutide)Stronger gastrointestinal side effects, fluid loss, no safety data – manufacturers advise against it
GLP-1 drug + insulin or sulfonylureasLow blood sugar; according to the prescribing information the dose of these drugs often needs medical adjustment
Growth-hormone peptides (e.g. CJC-1295, ipamorelin, MK-677) with diabetes or prediabetesCan raise blood sugar and worsen insulin action
Several substances from the doping listFor competing athletes: a doping violation; some substances also fall under the German Anti-Doping Act

On top of that come interactions with ordinary medicines – see Weight-loss injection interactions.

Where combinations are actually tested

Combinations can make sense – but only if they are studied systematically. One example is CagriSema, the combination of cagrilintide and semaglutide, which was tested in large phase 3 trials. Exactly these kinds of studies are missing for the stacks circulating online. Tirzepatide is basically a “tested combination” too: two mechanisms in one molecule, approved after large trials.

What to watch out for

  • Discuss every combination – including supplements – with your doctor and name all substances honestly.
  • Don't take two drugs with the same mechanism (e.g. two GLP-1 drugs).
  • If you take diabetes medication: keep an eye on your blood sugar and know the warning signs of hypoglycaemia.
  • Write down exactly what you take and when – the tracker helps you match side effects.
  • Don't be guided by “stack recommendations” in groups or shops – they are not based on studies.

Note: This page gives no recommendations for combinations or doses of unapproved substances. It does not replace medical advice.

When to see a doctor

  • Trembling, sweating, ravenous hunger or confusion (possible low blood sugar)
  • Persistent vomiting or diarrhoea with signs of dehydration
  • Severe upper abdominal pain radiating to the back
  • Racing heart, shortness of breath or swelling after a new combination

In an emergency: 112.

FAQ

Can you take BPC-157 and TB-500 together?

There are no human studies on this popular combination – neither on efficacy nor on safety. Neither substance is approved as a medicine, and both are on the doping list.

Can tirzepatide and retatrutide be combined?

No, this is not advisable. Both act via GLP-1; together, side effects add up and there is no safety data. Retatrutide is also not approved anywhere.

Is a peptide blend the same as a stack?

In principle, yes: a blend is a ready-mixed stack in one vial. It has the same open questions and, on top of that, can't be adjusted individually.

Which combinations have been tested?

Only those studied in clinical trials, for example CagriSema (cagrilintide + semaglutide). For most stacks advertised online there is no such data.

Sources

This article does not replace medical advice. It gives no dosing recommendations. As of September 2026.